A number of adverse effects have been described with the use of gonadotropin releasing hormone agonist (GnRHa) therapy in children namely, localized reaction at the site of injection such as pain, erythema, rash, infection or abscess formation and systemic effects such as headache, syncope, fever, or weight gain. These effects have been reported in fewer than 2% of patients receiving GnRHa.
While psychological changes have been reported in adult women receiving therapy, these types of adverse events have not been well documented in children. In this report, we describe 3 distinct cases of acute behavioral problems including emotional lability and aggression that were observed in patients being treated with GnRHa implant for central precocious puberty and with dramatic improvement of psychologic changes upon the discontinuation of therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.